Euromedis Groupe SA Market Cap ($14.57 Million)
Market Cap & Net Worth: Euromedis Groupe SA (ALEMG)
Euromedis Groupe SA market cap. Euromedis Groupe SA (PA:ALEMG) has a market capitalization of $14.57 Million (€12.46 Million) as of November 5, 2026. Listed on the PA stock exchange, this France-based company holds position #25907 globally and #427 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Euromedis Groupe SA's stock price €5.50 by its total outstanding shares 2855990 (2.86 Million). Also see ALEMG operating cash flow for how efficiently the company converts equity into cash flow.
Euromedis Groupe SA Market Cap History (2015–2026)
Euromedis Groupe SA market cap history from 2015 to 2026. Data shows change from $20.81 Million to $18.36 Million (-1.35% CAGR). Check Euromedis Groupe SA stock price for real-time trading data and today's change.
Euromedis Groupe SA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Euromedis Groupe SA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore ALEMG net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.32x
Euromedis Groupe SA's market cap is 0.32 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $23.20 Million | $73.17 Million | $1.01 Million | 0.32x | 23.04x |
| 2017 | $23.97 Million | $73.60 Million | -$146.00K | 0.33x | N/A |
| 2018 | $22.04 Million | $76.06 Million | -$4.92 Million | 0.29x | N/A |
| 2019 | $15.16 Million | $77.08 Million | -$3.80 Million | 0.20x | N/A |
| 2020 | $45.74 Million | $193.41 Million | $22.66 Million | 0.24x | 2.02x |
| 2021 | $35.06 Million | $111.90 Million | $2.26 Million | 0.31x | 15.54x |
| 2022 | $16.06 Million | $54.18 Million | -$5.96 Million | 0.30x | N/A |
| 2023 | $17.76 Million | $37.43 Million | $13.11 Million | 0.47x | 1.35x |
| 2024 | $14.69 Million | $36.22 Million | -$6.11 Million | 0.41x | N/A |
| 2025 | $13.09 Million | $40.80 Million | -$131.77K | 0.32x | N/A |
Competitor Companies of ALEMG by Market Capitalization
Companies near Euromedis Groupe SA in the global market cap rankings as of November 5, 2026. Also see ALEMG total asset value for a full breakdown of the balance sheet.
Key companies related to Euromedis Groupe SA by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #249 globally with a market cap of $101.38 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #450 globally with a market cap of $61.32 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #625 globally with a market cap of $43.01 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1140 globally with a market cap of $22.79 Billion USD ( AU$32.21 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #249 | McKesson Corporation | NYSE:MCK | $101.38 Billion | $1069.44 |
| #450 | Cencora Inc. | NYSE:COR | $61.32 Billion | $354.00 |
| #625 | Cardinal Health Inc | NYSE:CAH | $43.01 Billion | $261.93 |
| #1140 | Sigma Healthcare Ltd | AU:SIG | $22.79 Billion | AU$2.79 |
Market Capitalization of Euromedis Groupe SA (2015–2026)
Market capitalization of Euromedis Groupe SA from 2015 to today. Between 2015 and today, Euromedis Groupe SA's market cap moved from $20.81 Million to $ 18.36 Million, with a yearly change of -1.35%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €18.36 Million | +40.31% |
| 2025 | €13.09 Million | -10.91% |
| 2024 | €14.69 Million | -17.29% |
| 2023 | €17.76 Million | +10.60% |
| 2022 | €16.06 Million | -54.19% |
| 2021 | €35.06 Million | -23.36% |
| 2020 | €45.74 Million | +201.76% |
| 2019 | €15.16 Million | -31.21% |
| 2018 | €22.04 Million | -8.08% |
| 2017 | €23.97 Million | +3.32% |
| 2016 | €23.20 Million | +11.48% |
| 2015 | €20.81 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of Euromedis Groupe SA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $14.57 Million USD |
| MoneyControl | $14.57 Million USD |
| MarketWatch | $14.57 Million USD |
| marketcap.company | $14.57 Million USD |
| Reuters | $14.57 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Euromedis Groupe SA
Laboratoires Euromedis Société anonyme manufactures, imports, and distributes single-use medical devices for public and private healthcare facilities. It provides gloves; clothing and protection; draping and fields; compresses, cotton, dressings, strips and nets, and skincare products; sets and instrumentation; needles, syringes, micro perfusionists; infusion and transfusion services, catheters, … Read more